Trials / Completed
CompletedNCT00504257
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
A Phase II Trial of Avastin in Combination With Docetaxel in Patients With Recurrence of Epithelial Carcinoma of the Ovary/Fallopian Tube/Peritoneum Within 12 Months of Platinum Therapy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of the combination of Avastin and Docetaxel in the treatment of women with platinum sensitive recurrent epithelial ovarian cancer within 12 months of platinum chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Avastin | Day 1, every 21 day cycle |
| DRUG | Docetaxel | Day 1, 8, every 21 day cycle |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2007-07-19
- Last updated
- 2014-02-06
- Results posted
- 2013-10-11
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00504257. Inclusion in this directory is not an endorsement.